Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.
机构:[1]Third Surgery Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.河北医科大学第四医院外三科临床科室[2]Department of Gastrointestinal Surgery, Hengshui People's Hospital, Hengshui, China.
第一作者机构:[1]Third Surgery Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.[2]Department of Gastrointestinal Surgery, Hengshui People's Hospital, Hengshui, China.
通讯作者:
通讯机构:[1]Third Surgery Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
推荐引用方式(GB/T 7714):
Guo Zhenjiang,Guo Honghai,Tian Yuan,et al.Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.[J].FRONTIERS IN ONCOLOGY.2022,12:doi:10.3389/fonc.2022.908229.
APA:
Guo Zhenjiang,Guo Honghai,Tian Yuan,Zhang Ze&Zhao Qun.(2022).Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery..FRONTIERS IN ONCOLOGY,12,
MLA:
Guo Zhenjiang,et al."Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.".FRONTIERS IN ONCOLOGY 12.(2022)